Glutathione peroxidase, glutathione-S-transferase, catalase, xanthine oxidase, Cu-Zn superoxide dismutase activities, total glutathione, nitric oxide, and malondialdehyde levels in erythrocytes of patients with small cell and non-small cell lung cancer

被引:110
作者
Kaynar, H
Meral, M [1 ]
Turhan, H
Keles, M
Celik, G
Akcay, F
机构
[1] Ataturk Univ, Sch Med, Dept Chest Dis, TR-25240 Erzurum, Turkey
[2] Ataturk Univ, Sch Med, Dept Biochem, TR-25240 Erzurum, Turkey
[3] Ataturk Univ, Sch Med, Dept Internal Med, TR-25240 Erzurum, Turkey
关键词
malondialdehyde; glutathione; glutathione peroxidase; superoxide dismutase; nitric oxide; small cell and non-small cell lung cancer;
D O I
10.1016/j.canlet.2004.12.005
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Lung cancer is a common pathology with high mortality due to late diagnosis. Glutathione peroxidase (GSH-Px), glutathione-S-transferase (GST), catalase (CAT), xanthine oxidase (XO), Cu-Zn superoxide dismutase (Cu-Zn SOD) activities, total glutathione (TGSH), nitric oxide (NO center dot), and malondialdehyde (MDA) levels were investigated in erythrocytes of patients with non-small-cell lung cancer (NSCLC) and small-cell lung cancer (SCLC), and healthy control group. We aimed to investigate serum GSH, GSH-dependent enzymes activities (GSH-Px and GST), XO, CAT, Cu-Zn SOD activity, and NO center dot, and MDA levels in patients with NSCLC and with SCLC and correlate with the cancer stage. Erythrocyte MDA, NO center dot, TGSH levels and erythrocyte SOD, CAT and XO activities were significantly higher in patients with NSCLC and SCLC than in controls. Slightly increased erythrocyte GSH-Px and GST activities were not significantly different from the controls. Erythrocyte MDA level positively correlated with erythrocyte NO center dot levels in patients with early stage (I+II) in NSCLC groups. Erythrocyte MDA level positively correlated with erythrocyte XO activity in patients with advanced stage (III+IV) in NSCLC groups. However, no other correlation could be found among the parameters in healthy controls and patients with NSCLC and with SCLC. Results obtained in this study indicate significant changes in antioxidant defence system in NSCLC and SCLC patients, which may lead to enhanced action of oxygen radical, resulting in lipid peroxidation. (C) 2004 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:133 / 139
页数:7
相关论文
共 45 条
[1]  
Aktan B, 2003, ANN CLIN LAB SCI, V33, P232
[2]   Nitric oxide levels and lipid peroxidation in plasma of patients with gastric cancer [J].
Bakan, E ;
Taysi, S ;
Polat, MF ;
Dalga, S ;
Umudum, Z ;
Bakan, N ;
Gumus, M .
JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2002, 32 (05) :162-166
[3]   Glutathione peroxidase, glutathione reductase, Cu-Zn superoxide dismutase activities, glutathione, nitric oxide, and malondialdehyde concentrations in serum of patients with chronic lymphocytic leukemia [J].
Bakan, N ;
Taysi, S ;
Yilmaz, Ö ;
Bakan, E ;
Kuskay, S ;
Uzun, N ;
Gündogdu, M .
CLINICA CHIMICA ACTA, 2003, 338 (1-2) :143-149
[4]   Metabolic oxidative stress activates signal transduction and gene expression during glucose deprivation in human tumor cells [J].
Blackburn, RV ;
Spitz, DR ;
Liu, X ;
Galoforo, SS ;
Sim, JE ;
Ridnour, LA ;
Chen, JC ;
Davis, BH ;
Corry, PM ;
Lee, YJ .
FREE RADICAL BIOLOGY AND MEDICINE, 1999, 26 (3-4) :419-430
[5]  
BORIES PN, 1995, CLIN CHEM, V41, P904
[6]   Nitric oxide in patients with transitional bladder cancer [J].
Eiján, AM ;
Piccardo, I ;
Riveros, MD ;
Sandes, EO ;
Porcella, H ;
Jasnis, MA ;
De Lustig, ES ;
Malagrino, H ;
Pasik, L ;
Casabé, AR .
JOURNAL OF SURGICAL ONCOLOGY, 2002, 81 (04) :203-208
[7]   ANTIOXIDANT ENZYMES IN LYMPHOCYTES FROM NORMAL SUBJECTS AND PATIENTS WITH CHRONIC LYMPHOCYTIC-LEUKEMIA - INCREASED GLUTATHIONE-PEROXIDASE ACTIVITY IN CLL LYMPHOCYTES-B [J].
FARBER, CM ;
KANGANIS, DN ;
LIEBES, LF ;
SILBER, R .
BRITISH JOURNAL OF HAEMATOLOGY, 1989, 72 (01) :32-35
[8]   INCREASED GLUTATHIONE IN CHRONIC LYMPHOCYTIC-LEUKEMIA LYMPHOCYTES [J].
FERRARIS, AM ;
ROLFO, M ;
MANGERINI, R ;
GAETANI, GF .
AMERICAN JOURNAL OF HEMATOLOGY, 1994, 47 (03) :237-238
[9]   Oxidant antioxidant status alterations in cancer patients: Relationship to tumor progression [J].
Gerber, M ;
Astre, C ;
Segala, C ;
Saintot, M ;
Scali, J ;
SimonyLafontaine, J ;
Grenier, J ;
Pujol, H .
JOURNAL OF NUTRITION, 1996, 126 (04) :S1201-S1207
[10]   Plasma malondialdehyde (MDA) levels in breast and lung cancer patients [J].
Gönenç, A ;
Özkan, Y ;
Torun, M ;
Simsek, B .
JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, 2001, 26 (02) :141-144